SCHEDULE 13D/A: Saba Capital Reduces Stake in Nuveen Core Plus Impact Fund Amidst Recent Share Sales

Saba Capital Management, L.P. and its affiliates have filed an Amendment No. 8 to their Schedule 13D, disclosing a beneficial ownership of 6.08% in Nuveen Core Plus Impact Fund following a series of open market share sales.

Summary

• Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (collectively, the "Reporting Persons") jointly filed Amendment No. 8 to Schedule 13D.
• The filing pertains to their beneficial ownership of Common Shares, $0.01 par value, of Nuveen Core Plus Impact Fund.
• As of February 24, 2025, the Reporting Persons beneficially own an aggregate of 1,749,491 common shares.
• This represents 6.08% of the outstanding common stock, calculated based on 28,755,000 shares outstanding as of June 30, 2024, as disclosed in the company's N-CSRS filed September 5, 2024.
• Funds for the acquisition of these shares, totaling approximately $20,301,751, were derived from investor subscription proceeds, capital appreciation, and ordinary course margin account borrowings.
• Between February 7, 2025, and February 24, 2025, Saba Capital executed a series of open market sales of Nuveen Core Plus Impact Fund common shares, totaling 303,830 shares at prices ranging from $10.80 to $10.93 per share.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the disclosure of significant share sales by a major institutional investor, which can be interpreted as a lack of conviction or a strategic divestment.

Negatives

• A significant institutional investor, Saba Capital, has reduced its stake in Nuveen Core Plus Impact Fund through a series of open market sales, which could be perceived as a negative signal regarding their outlook on the fund.

Future Outlook

The document does not provide any forward-looking statements or guidance from the issuer or the reporting persons regarding the future outlook of Nuveen Core Plus Impact Fund.

Industry Context

This filing reflects the ongoing activity of Saba Capital, a prominent activist investor known for its focus on closed-end funds. Their reduction in stake in Nuveen Core Plus Impact Fund could be part of a broader portfolio rebalancing or a strategic move within their investment thesis for closed-end funds, potentially influencing other investors' perceptions of the fund.

Legal Proceedings

• The Reporting Persons (Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein) have not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years.
• The Reporting Persons have not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws, or finding any violation with respect to such laws, during the last five years.

Stakeholder Impact

• Shareholders: The reduction in stake by a significant institutional investor like Saba Capital could lead to decreased investor confidence and potentially impact the fund's share price.
• Management: May face increased scrutiny or pressure if the selling activity is perceived as a vote of no confidence in the fund's strategy or performance.

Key Dates

Recommendation

Keywords

Nuveen Core Plus Impact Fund, Saba Capital Management, Schedule 13D, beneficial ownership, closed-end fund, institutional investor, share sales, investment management